Načítá se...
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
FDA approved for parasitic indications, the small molecule ivermectin has been the focus of growing attention in the last 8 years due to its potential as an antiviral. We first identified ivermectin in a high throughput compound library screen as an agent potently able to inhibit recognition of the...
Uloženo v:
| Vydáno v: | Biochem Biophys Res Commun |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Published by Elsevier Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7577703/ https://ncbi.nlm.nih.gov/pubmed/33341233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2020.10.042 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|